Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3021% above fair value
$19.55−0.62 (-3.07%)
Close on Nov 19, 2026Market cap $990.19MP/E –Yield –
Cryoport free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cryoport's free cash flow for the twelve months ending Jun 30, 2026 was -$20.03M. For fiscal 2025 it was -$25.02M. The highest annual figure on record is -$4.20M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$25.02M | – |
| FY2024 | Dec 31, 2024 | -$33.58M | – |
| FY2023 | Dec 31, 2023 | -$39.54M | – |
| FY2022 | Dec 31, 2022 | -$23.96M | – |
| FY2021 | Dec 31, 2021 | -$15.76M | – |
| FY2020 | Dec 31, 2020 | -$23.78M | – |
| FY2019 | Dec 31, 2019 | -$6.66M | – |
| FY2018 | Dec 31, 2018 | -$6.27M | – |
| FY2016 | Mar 31, 2016 | -$7.42M | – |
| FY2015 | Mar 31, 2015 | -$4.20M | – |
| FY2014 | Mar 31, 2014 | -$4.52M | – |
| FY2013 | Mar 31, 2013 | -$4.94M | – |
| FY2012 | Mar 31, 2012 | -$7.04M | – |
| FY2011 | Mar 31, 2011 | -$5.15M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -$7.97M | – |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -$6.25M | – |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -$4.55M | – |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -$1.27M | – |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | -$11.70M | – |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -$7.51M | – |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -$10.70M | – |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | -$3.79M | – |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -$11.82M | – |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -$7.27M | – |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -$9.09M | – |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -$10.93M | – |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -$12.73M | – |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -$6.80M | – |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -$4.20M | – |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -$4.21M | -16932.0% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -$11.83M | – |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -$3.72M | – |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -$5.71M | – |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | $25.00K | – |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -$1.27M | – |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -$8.80M | -2001.1% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -$13.51M | – |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -$7.42M | – |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -$3.32M | – |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | $463.00K | – |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -$406.18K | – |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -$2.42M | – |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -$2.52M | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -$1.31M | – |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -$1.44M | – |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -$1.53M | – |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -$1.96M | – |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -$1.33M | – |
| Q4 FY2016CQ1 2016 | Mar 31, 2016 | -$2.37M | – |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -$1.77M | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -$1.29M | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -$1.98M | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | -$1.29M | – |
| Q3 FY2015CQ4 2014 | Dec 31, 2014 | -$1.06M | – |
See a number that looks wrong?